Jiangsu Alpha Pharmaceutical Co., Ltd.

Products

tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)- acetate

    • Product Name: tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)- acetate
    • Chemical Name (IUPAC): tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
    • CAS No.: 866594-46-1
    • Chemical Formula: C13H23ClO4
    • Form/Physical State: Liquid
    • Factroy Site: Yinchuan, Ningxia, China
    • Price Inquiry: sales8@bouling-chem.com
    • Manufacturer: Jiangsu Alpha Pharmaceutical Co., Ltd.
    • CONTACT NOW
    VTB
    Specifications
    HS Code 232114
    Product Name tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate
    Molecular Formula C12H21ClO4
    Molecular Weight 264.75 g/mol
    Cas Number 292661-89-9
    Appearance Colorless to pale yellow liquid
    Density Approx. 1.11 g/cm3
    Purity Typically >95%
    Structural Features Contains dioxane and chloroalkyl moieties
    Stereochemistry 4R,6S configuration
    Functional Groups Acetate ester, dioxane, chloromethyl
    Solubility Soluble in organic solvents (e.g., dichloromethane)

    As an accredited tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)- acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The chemical is packaged in a 25g amber glass bottle with a tamper-evident screw cap, labeled with safety and identification information.
    Container Loading (20′ FCL) 20′ FCL container loaded with securely packed tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate, ensuring safe chemical transport.
    Shipping This chemical is shipped in specialized, leak-proof containers compliant with hazardous material regulations. Temperature control, ventilation, and secure packaging prevent contamination and degradation. All shipments include proper labeling (UN number, hazard class), safety data sheets (SDS), and documentation to ensure safe handling during transport. Shipping must adhere to local and international chemical transport guidelines.
    Storage Store tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate in a tightly sealed container, protected from light and moisture, in a cool, dry, and well-ventilated area. Keep away from sources of ignition, strong oxidizing agents, and incompatible chemicals. Ensure proper chemical labeling and secondary containment, and use gloves and eye protection when handling to avoid exposure.
    Shelf Life Shelf life: Store tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate at 2-8°C, stable for 2 years.
    Application of tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)- acetate

    Applications of tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate in Industrial Manufacturing

    As a specialist producer of tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate, we supply this strategic intermediate primarily to manufacturers engaged in pharmaceutical synthesis, advanced agrochemical development, and specialty chemical research. Below, we detail how leading enterprises in regulated downstream sectors integrate this material into their core manufacturing processes, highlighting essential compliance frameworks, real-world formulation usage, stepwise process inclusion, and end-product categories.

    1. Chiral Pharmaceutical Intermediates for Antiviral APIs

    Pharmaceutical ingredient manufacturers rely on this compound as a key chiral building block in the multi-step synthesis of nucleoside-based antiviral drugs. Downstream users leverage its stereochemical properties to ensure the enantioselectivity vital for drug efficacy and safety, especially in the large-scale production of intermediate structures en route to APIs such as lamivudine and emtricitabine. Operations maintain strict traceability and documentation due to the sensitive use within GMP environments.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    2. Advanced Agrochemical Synthesis: Fungicide Precursor Manufacturing

    Leading agrochemical plants incorporate this raw material as a protected glycosyl intermediate during the synthesis of chloromethyl-containing dioxane rings, which serve as starting points for further elaboration into advanced fungicide actives. Its use enables precision control of functional group introduction, resulting in potent and selective actives for integrated pest management programs. Downstream labs tightly monitor reaction parameters to comply with environmental and product registration requirements.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    3. Carbohydrate Chemistry for Nucleoside Analogue Synthesis in Research

    Specialty chemical and academic laboratories utilize this compound as a protected sugar derivative in carbohydrate chemistry workflows, primarily to create complex nucleoside analogues used in investigational drug and diagnostic probe research. Researchers value the stability offered by its tert-butyl and acetal protections during multi-step synthetic routes, ensuring selectivity in the manipulation of sensitive functional groups. Rigorous lab protocols support material handling and downstream chromatography.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    4. Synthesis of Functionalized Fine Chemical Intermediates

    Producers of fine chemicals and custom intermediates employ this specialty intermediate during the construction of highly functionalized dioxane compounds, often destined for further elaboration in the life sciences, flavors, and high-end material sectors. Downstream operators appreciate the controlled chloromethyl introduction facilitated by this raw material, which is critical for producing stable, isolated intermediates with high purity. Dedicated quality protocols underpin consistent performance in batchwise and continuous operations.

    Industry compliance standards

    Typical usage ratio

    Downstream process integration

    Final product types

    Free Quote

    Competitive tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)- acetate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8618005193850

    Email: sales8@bouling-chem.com

    Inquiry

    Get Free Quote of Jiangsu Alpha Pharmaceutical Co., Ltd.

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Tert-Butyl 2-((4R,6S)-6-(Chloromethyl)-2,2-Dimethyl-1,3-Dioxan-4-yl)-Acetate: Our Experience and Perspective

    Shaping Reliable Building Blocks through Chemical Precision

    Years in chemical manufacturing have shown us that progress in research and synthesis leans on trust in the quality and reliability of every intermediate. Our facility produces tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate to meet exacting standards demanded by both scale and discovery. This molecule, though appearing niche, supports work in advanced pharmaceutical research, agrochemical development, and specialty materials where stereochemical purity and stability matter most. Through our controlled processes and attention to detail, we offer a product that lets others push boundaries in their own sectors, knowing foundation steps are secure.

    Our Approach to Manufacturing and Model Selection

    We see the value in proper model selection every day. For tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate, strict attention guides our choice of raw materials—resorting only to high-purity precursors with audited origins. The model offered reflects repeatable structure confirmation through NMR, HPLC, and mass spectrometry, and customers have shared their appreciation for a consistent batch-to-batch molecular configuration. Plant-floor observation keeps our crew engaged in verification, not just by machine readout but by smell, texture, and the way the product responds in known reactions—the marks of an engaged manufacturing team with skin in the game.

    It gets easy to overlook the way stereochemistry shapes the destiny of an intermediate. Our process stays tuned to the 4R,6S configuration, so the end-user receives a substance primed for specific catalytic steps or protecting group strategies. Not every source tracks the handedness of the dioxane ring with the same obsession over detail. Sacrificing vigilance here shortchanges downstream synthesis, at times churning out wasted effort and resources. We have found that the benefit of obsessive attention early in manufacturing pays dividends in our own internal tests, saving more expensive final-stage corrections and making our partners’ downstream chemistry less frustrating.

    Specifications and Their Implications

    Delivering tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate, we focus on practical aspects. Careful drying steps achieve low moisture, proven through Karl Fischer titration, because even minor water residues skew reactivity and shelf-life. We filter particulates against precise micron thresholds to reduce the burden of post-synthesis purification. The product arrives as a colorless to pale yellow oil or solid, packaging adjusted seasonally to maintain practical handling temperatures and ensure material extraction remains smooth—no one wants to scrape inside a drum in the middle of winter or chase runaway liquid on a hot summer day.

    Transparency about physical properties and solvent residuals comes naturally to us. We share measurements of density, melting point (if applicable), and identities of trace solvents leftover from work-up. Real conversations with chemists reflect a shared understanding—unexpected boiling points or phase separation frustrate pilots and scale-ups. With every lot, we log spectroscopic signatures so our partners don’t waste time double-checking what’s on the invoice against what’s in the flask. Our confidence comes not just from instruments, but from accumulated hands-on familiarity.

    How Practical Experience Drives Better Products

    Our daily routines center on more than purity graphs. Living with tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate—the way it pours, how it resists hydrolysis, and how it stands up to temperature cycling—turns technical requirements into lived realities. For example, several customers contacted us about oxidative stability when attempting late-stage modifications. These conversations led to a continuous improvement checkpoint, where we altered our own storage and shipping environments, introducing light-blocking containers and robust nitrogen blanketing. In practice, this move reduced minor degradation, producing product less prone to off-odors or yellowing over time. Experience sharpened our sense that even minor details in logistics ripple through downstream R&D.

    As a manufacturer, technical paperwork alone never tells the full story. Walk a production floor and you notice that this intermediate resists sticking to most plastics, but glass vials remain easier for loading precise analytical aliquots. Industrial scales let us sequence operations flexibly, switching between small-batch pilot runs and hundreds-of-kg campaigns as customer needs fluctuate. Not every substance rewards this approach—exotic hydrolysable groups demand workflow adaptation, and not every line worker relishes frequent product changeovers. Here, collaborative problem-solving means that a worker seeing an unexpected viscosity or color shift can flag a problem before it enters a customer's facility, based on intuition earned over repeated production runs.

    What Sets Our Intermediate Apart

    Broad chemical supply houses offer a dizzying range of intermediates, many of them with less attention to batch regularity or historical performance. Our record keeping spans years, allowing us to spot long-term trends across batches. We keep logs of process troubleshooting and share them across shifts, so institutional memory guards against repeated errors. Terbutyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate rewards this effort, as its nuanced dioxane architecture shows sensitivity to minor pH swings and reagent impurities. We see competitors rush scale-up runs, sometimes introducing cloudiness or unplanned byproducts that complicate later transformations. Ours preserves clarity and reactivity, backed up by both process data and field feedback from synthesizing chemists frustrated by earlier, unreliable sources.

    We often get requests to compare with similar acetates or dioxan-yl intermediates. The 4R,6S-isomer, coupled with the tert-butyl ester group, offers greater resistance to premature deprotection under basic conditions without prolonging final cleavage during target molecule construction. For those in pharma, this means more predictable synthesis, less time spent troubleshooting instability, and fewer headaches scaling from benchtop to pilot plant. Our customers have commented on the ease with which they can carry the protected fragment through multi-step sequences, reducing material losses and limits on route flexibility.

    A Manufacturer’s Take on Usage in Complex Synthesis

    Our time listening to the real-world struggles of synthetic chemists shaped our dosing and bottling practices. Bulk users requested larger drums, but researchers on rapid screening projects favored aliquots suited to glovebox transfer. By running both formats in tandem, we serve small experimenters and full-scale manufacturers alike, always offering support for techniques ranging from batchwise addition to continuous feed systems. Batch documentation, traceable back to input solvent lots and final in-line chromatograms, means one can reconstruct every step if a downstream hiccup occurs.

    Working closely with process development experts in pharma has made clear that not every sourcing headache gets solved by lab purity alone. What matters, often, is whether the intermediate we provide permits late-stage functionalizations, selective removals, and preservation of chirality. We leveraged our own in-house pilot plant to run customized studies for a handful of partners. Our data shows that the chloromethyl group remains available for substitution under mild, widely used conditions, but doesn’t overreact or drive unwanted side reactions common with less robust dioxane derivatives. Lab workers from partner groups have confirmed less time spent monitoring for overalkylation or byproduct buildup in their most complex routes.

    Meeting Analytical and Regulatory Demands

    Attention to compliance resides in our culture. Years ago, we wrestled with an unexpected impurity flagged in a routine chromatographic scan, which led to months of in-house method development and tighter solvent inventory control. We now keep complete traceability for each raw material shipment, through production, to outgoing product. For regulated industries, such provenance fosters real peace of mind. We retain primary standards to check against product identity during every campaign and store split samples of each lot for after-the-fact retesting, if partners need to investigate long-term material behavior.

    We share detailed certificates of analysis and provide a dossier of typical physical and chemical properties, incorporating third-party results where relevant for audits. Having direct control over every manufacturing step makes all the difference—if an anomaly slips through, everyone from shift supervisor to analytical chief feels a shared stake in delivering a resolution. Unlike those who merely act as intermediaries, our boots stay firmly on the factory floor, giving us fingertip feel for the particularities of each run.

    Responsiveness to Partner Feedback and Ongoing Improvement

    Feedback cycles with customers keep us on course. Some years back, a customer challenged us to improve the product’s shelf stability for extended storage under variable warehouse conditions. This led us to experiment with different packaging technologies and desiccant systems, culminating in a nitrogen-purged, light-resistant container that significantly prolonged integrity. Attention to these kinds of details isn’t an abstract exercise for us—it’s rooted in direct relationships with the people using the product, and steers our R&D investments toward real problems, not theoretical what-ifs.

    We’ve learned to let troubleshooting experiences shape our production philosophy. One especially memorable incident involved an unexpected gelation during a scale-up for a high-throughput screening project. Rather than deflecting blame, our team hosted the customer’s chemists at our plant, running through simulated process tweaks with them onsite. Collaborating over the reactor kettles reinforced a mutual learning dynamic. We brought the lessons home, updating our internal training and introducing in-process checkpoints that continue to benefit all our output.

    Quality through Consistency and Human Touch

    Consistency stays in focus from weigh-in of starting reagents to placement of filled drum onto the shipping pallet. Each lot comes subject to double-checks using in-house and reference labs, not just as a record-keeping step but as a dialogue among team members. Problems turn up most often not in unexpected impurity spikes, but subtle shifts in viscosity, pourability, or color—a level of observation missed outside a hands-on manufacturing operation.

    We rely on cumulative experience to spot the difference between products that ‘meet spec’ and those customers rave about. A batch can look identical on paper, but subtle tactile cues and familiar production cues cue us to retest or reroute before any shipment. Quality isn’t just about numbers—it’s about the confidence that professionals downstream can proceed without worrying that fundamentals were shortchanged for expedience.

    Supporting Modern Research and Process Development

    Modern synthesis rarely chases off-the-shelf solutions. Those in process chemistry and medicinal research want intermediates that harmonize protection, stability, and reactivity, rather than a one-size-fits-all compromise. Years supplying tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate convinced us that chemists prefer tools with known performance envelopes. Our direct control means researchers don’t lose time recalibrating expectations or adapting variable product properties.

    We have seen our intermediate play roles in multi-step total syntheses, patent-breaching routes, and scale-up of key chiral centers. With each application comes a new round of scrutiny—will this batch resist hydrolysis as before, will stereochemistry remain as sharp, will residuals be low enough for direct coupling? Our hands-on approach, from process design to analytical sign-off, means the answer stays yes, maintaining trust across every kilo and every project.

    Comparing with Other Available Compounds

    Unlike some common dioxane-protected acetates, our intermediate anchors processes where chemoselectivity and chirality guide every downstream step. The robustness of the tert-butyl group slows premature ester hydrolysis without forcing users to escalate to harsh conditions for deprotection. In pharmaceutical and crop-protection laboratories, this advantage shortens timelines and shrinks synthesis variability.

    Other isomers and protecting groups often fall short when faced with repeated cycles of reaction and purification—especially at larger scale. Past users told us about instances where alternative intermediates from less attentive suppliers turned unreliable, laced with side-products or varying in melting point from lot to lot, threatening the integrity of their entire campaigns. Our longer-term users return year after year, affirming that predictable composition and behavior translates to fewer surprises and greater freedom in method development.

    Direct Control and Community Accountability

    Full accountability sits with us, not in a chain of faceless middlemen. From early planning with R&D partners to real-world troubleshooting of process upsets, we keep lines of communication open. We don’t hide behind standard documentation or disclaimers. When problems or opportunities appear, R&D and operations teams work together, and that knowledge stays on the factory floor—unlike outsourcing outfits who shift blame or confuse the origin of an issue.

    This connection supports more than reliable shipments. Running a plant demands responsibility, to both employees and customers, for safe handling of specialized intermediates. Safety evaluations remain an ongoing, living process, not a one-time box-ticking exercise. Clear, actionable data, maintained over years, creates better outcomes for our community of users and employees alike.

    Toward More Predictable and Sustainable Chemistry

    Science moves forward when uncertainty shrinks. Consistency in intermediates tightens control over complex syntheses, lets process engineers reduce buffer space around variable from step to step, and allows R&D groups to devote more effort to innovation instead of work-arounds. Our own journey making tert-butyl 2-((4R,6S)-6-(chloromethyl)-2,2-dimethyl-1,3-dioxan-4-yl)-acetate sharpened our conviction that practical, reliable tools enable the most exciting advances in chemistry.

    Behind each drum or bottle sits a team committed to mutual learning—with both the hands to tweak production and the ears to listen to partners. Facing new challenges in synthesis, protection-group innovation, or green chemistry, we put lessons from experience to work, refining both the product and the partnership every step of the way.